r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans.

Source:http://linkedlifedata.com/resource/pubmed/id/19029226

Download in:

View as

General Info

PMID
19029226